BTCC / BTCC Square / Global Cryptocurrency /
Cathie Wood’s ARK Invest Shifts Portfolio: Boosts Biotech, Trims Tech

Cathie Wood’s ARK Invest Shifts Portfolio: Boosts Biotech, Trims Tech

Published:
2025-10-29 02:54:02
19
3
BTCCSquare news:

Cathie Wood's ARK Invest made significant portfolio adjustments on October 28, 2025, doubling down on biotech while reducing exposure to tech favorites. The firm added $16.46 million in DraftKings shares across three ETFs, signaling confidence in the sports betting sector as regulatory barriers fall. Gene-editing pioneer Intellia Therapeutics saw a $7.09 million infusion, reinforcing ARK's conviction in CRISPR technologies.

Meanwhile, the investment manager continued unwinding positions in Shopify and Palantir, reflecting a strategic rotation from mature tech plays to disruptive healthcare innovations. The moves highlight ARK's signature focus on paradigm-shifting technologies, though notably absent any cryptocurrency-related adjustments in this trading session.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.